Another Activist Investor Joins Calls For GSK Leadership Review
Bluebell Capital Has Already Ousted One CEO
A second activist investor has called for GSK to consider replacing Emma Walmsley as CEO
, and has underlined competitive threats to a key pipeline candidate.
You may also be interested in...
GSK has poached its new chief financial officer from fashion brand Burberry, but Julie Brown’s experience at AstraZeneca and Roche will give her insights into how to lead GSK into its next phase.
GSK is entering a new era, and CEO Emma Walmsley looks likely to use new finances for more targeted M&A.
Industry's big players report fourth quarter results over the next two weeks. Updates on leadership changes, growth targets and deal plans are among the hot topics.